Based on previously published known survival associations, sarcoma and HNSCC belong to the DMD‐suppressor group, since high DMD expression is associated with improved survival [9, 12, 26], while mesothelioma aligns with the DMD‐oncogenic group, since high DMD expression correlates with poorer survival [7]. The gene discussed is DMD; the disease is sarcoma.